Instrument Inactif

Communiqués ISTA Pharmaceuticals, Inc.

Actions

US45031X2045

Produits pharmaceutiques

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

Communiqués

24/04/12	ISTA Pharmaceuticals, Inc. : Bausch + Lomb and ISTA Pharmaceuticals Announce Early Termination of Hart-Scott-Rodino Waiting Period	PU
02/04/12	ISTA Pharmaceuticals, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of ISTA Pharmaceuticals, Inc.	PR
29/03/12	ISTA Pharmaceuticals, Inc. : The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of ISTA Pharmaceuticals, Inc. in Connection with the Sale of the Company to Bausch + Lomb	PR
28/03/12	ISTA Pharmaceuticals, Inc. : Law Offices of Howard G. Smith Announces Continued Investigation of ISTA Pharmaceuticals, Inc.	BU
28/03/12	ISTA Pharmaceuticals, Inc. : Law Firm Brower Piven Announces Investigation in Connection With the Acquisition of ISTA Pharmaceuticals, Inc. by Bausch + Lomb	BU
28/03/12	ISTA Pharmaceuticals, Inc. : Glancy Binkow & Goldberg LLP Announces Continued Investigation of ISTA Pharmaceuticals, Inc.	BU
28/03/12	ISTA Pharmaceuticals, Inc. : The Law Firm of Weiss & Lurie Investigates ISTA Pharmaceuticals, Inc.	BU
27/03/12	ISTA Pharmaceuticals, Inc. : The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of ISTA Pharmaceuticals, Inc. in Connection with the Sale of the Company to Bausch + Lomb	BU
27/03/12	ISTA Pharmaceuticals, Inc. : Holzer Holzer & Fistel, LLC Announces Investigation into the Proposed Buyout of ISTA Pharmaceuticals, Inc.	BU
27/03/12	ISTA Pharmaceuticals, Inc. : Harwood Feffer LLP Announces Investigation of ISTA Pharmaceuticals, Inc.	PR
27/03/12	ISTA Pharmaceuticals, Inc. : ISTA Pharmaceuticals Investor Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate the Acquisition of ISTA Pharmaceuticals, Inc. by Bausch + Lomb	BU
27/03/12	ISTA Pharmaceuticals, Inc. : Law Offices of Howard G. Smith Announces Investigation of ISTA Pharmaceuticals, Inc.	BU
27/03/12	ISTA Pharmaceuticals, Inc. : Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ista Pharmaceuticals Inc.	BU
27/03/12	ISTA Pharmaceuticals, Inc. : Ryan & Maniskas, LLP Announces Investigation of ISTA Pharmaceuticals, Inc.	BU
27/03/12	ISTA Pharmaceuticals, Inc. : Bernstein Liebhard LLP Announces Investigation of Acquisition of ISTA Pharmaceuticals, Inc. by Bausch + Lomb	PR
27/03/12	ISTA Pharmaceuticals, Inc. : Block & Leviton LLP Investigates ISTA Pharmaceuticals, Inc.'s Board of Directors for Possible Breaches of Fiduciary Duty	PR
27/03/12	ISTA Pharmaceuticals, Inc. : Glancy Binkow & Goldberg LLP Announces Investigation of ISTA Pharmaceuticals, Inc.	BU
27/03/12	ISTA Pharmaceuticals, Inc. : The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of ISTA Pharmaceuticals, Inc. in Connection with the Sale of the Company to Bausch + Lomb	BU
30/01/12	ISTA Pharmaceuticals, Inc. : ISTA's Board Reiterates Commitment to Maximizing Shareholder Value Through Strategic Review Process	PU
30/01/12	ISTA Pharmaceuticals, Inc. : Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuticals Inc.	PR
30/01/12	ISTA Pharmaceuticals, Inc. : ISTA Pharmaceuticals Completes Patient Enrollment in Phase 2 Clinical Study of BEPOSONE(TM) (Bepotastine Besilate - Steroid Combination Nasal Spray) for the Treatment of Symptoms Associated With Seasonal Allergic Rhinitis	PU
17/01/12	ISTA Pharmaceuticals, Inc. : ISTA's Board of Directors to Review Valeant's Revised Proposal as Part of Its Ongoing Review of Strategic Options	PU
16/12/11	ISTA Pharmaceuticals, Inc. : Bernstein Liebhard LLP Announces Investigation of Offer for ISTA Pharmaceuticals, Inc.	BU
18/10/11	ISTA Pharmaceuticals, Inc. : ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2011 Financial Results	PU
13/10/11	ISTA Pharmaceuticals, Inc. : ISTA Pharmaceuticals Reports Results From the Second of Two Studies in the REMURA(TM) Phase 3 Clinical Program for Dry Eye Disease	PU